Mi­rati is once again the cen­ter of buy­out ru­mors, and a ri­val's ad­comm pro­vides a boost

Mi­rati Ther­a­peu­tics is once again at­tract­ing buy­out in­ter­est, this time al­leged­ly from Sanofi, ac­cord­ing to a re­port from Bloomberg on Thurs­day. The biotech’s shares …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER